Leonid S. Aleksandrov

Leonid S. Aleksandrov

Auto-generated profile, based on publicly available information

Leonid S. Aleksandrov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2016 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
LAL. S. Aleksandrov
L. S. Aleksandrov
AIA. A. Ishchenko
A. A. Ishchenko
EHE. P. Hudoley
E. P. Hudoley
Objectives: According to different authors, the percentage of genital prolapse among gynaecological diseases that require surgical correction reaches 28−38,9%. Pelvic muscle wasting is a special kind of pelvic prolapse, often leading to cervical elongation and hypertrophy. Contemporary methods of treatment for this condition have the high rate of relapse― 8,9−22%, thus urging to improve the existing techniques. The purpose of this research was to estimate the effectiveness of novel modification of Manchester operation in comparison with classic Manchester operation in the management of pelvic prolapse with cervical elongation. Methods: We enrolled 83 patients with pelvic prolapse and cervical elongation and divided them into two groups. In GroupI (n=47) we used the novel surgical method, supplementing original Manchester procedure with cervical stump fixation and other improvements. In GroupII we used original Manchester procedure. We compared laboratory measures as well as surgery duration, blood loss, incidence of complications, and duration of post-operational hospital stay. Patients were followed-up for 2years to estimate long-term effectiveness of surgical intervention. Statistical analysis was performed in SPSS 17.0.Results: Surgery duration in GroupII was significantly longer (47,8±26,2 vs 57,5±35,1 minutes, p0.05). There were no significant differences in lab tests, post-operational hospital stay (5,2±0,9 vs 7,3±1,2) and incidence of post-operational complications (3 vs 4 cases). Over the 2 years of follow-up we registered 1 case of relapse in Group I and 3 cases of relapse in Group II, thus estimating the effectiveness of surgery as 97,9 vs 91,7%, a non-significant difference. We noticed that all relapsed women had signs of systemic dysplasia of connective tissue.Conclusion: Suggested modification of Manchester operation improves duration of surgical intervention itself, while providing a comparable level of effectiveness.

1 January 2020 in Voprosy Ginekologii, Akušerstva i Perinatologii
Verified
Journal Article
Closed access
EKE.V. Kirakosyan
E.V. Kirakosyan
ALAlexey Lyundup
Alexey Lyundup
LAL.S. Aleksandrov
L.S. Aleksandrov
ADAnna Demchenko
Anna Demchenko
AIA.I. Ishchenko
A.I. Ishchenko
MZM.N. Zholobova
M.N. Zholobova
The review analyses the results of using mesenchymal stem cells (MSCs) to restore fertility. Research works have shown that MSCs have the ability to differentiate into empryonic cells under specific induction conditions, and also when transplanted to gonadal tissue. Most studies were performed on MSCs obtained from bone marrow and the umbilical cord. Promising approaches related to the use of cell therapy have shown their high efficacy in preclinical studies: the infertility models in rats, mice and rabbits resulted in pregnancy after cell therapy. Research in this field is intensive: by now there is information about 11 preclinical and 12 clinical studies. The first results of clinical studies are positive. Clinical studies have been planned and started to determine the effect of MSCs transplantation on management of infertility, and their results, among others, will be decisive for introduction of cell therapy of infertility into clinical practice. The findings are promising, but further clinical research is needed to assess the efficacy and safety of MSCs transplantation for fertility restoration. Key words: infertility, gynaecology, treatment, MSCs, stem cells

30 March 2020 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
JDJulia V. Denisova
Julia V. Denisova
Ekaterina V. MandraEkaterina V. Mandra
Ekaterina V. Mandra
ALAlexey Lyundup
Alexey Lyundup
Yana Yu SulinaYana Yu Sulina
Yana Yu Sulina
LALeonid S. Aleksandrov
Leonid S. Aleksandrov
БВБереговых Валерий Васильевич
Береговых Валерий Васильевич
The article presents a review of publications devoted to the use of regenerative technologies in the treatment of gynecological pathologies. The authors describe possible ways to solve these problems by analyzing the experimental studies conducted in the world. Identified the main indications for tissue engineering: Ashermans syndrome, primary ovarian failure, infertility caused by chemotherapy, a niche in the uterus, endometrial pathology (endometriosis, endometrial problems, etc.), cervical pathology, female genital tract abnormalities, pelvic organ prolapse. The results of clinical trials of cell therapy aimed at treating infertility caused by Asherman syndrome and primary ovarian failure, female genital tract abnormalities, as well as such rare pathology as a niche of the uterus. At the preclinical stage, in addition to the above, considered cellular therapy of cervical pathologies, endometrial diseases and pelvic organ prolapse. Eximined cell cultures and the level of their influence on the regeneration of the female reproductive system structures, presented the biological scaffolds that stimulate the growth of stem cells, their effectiveness and shortcomings are covered.